Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory T-ALL/LBL
NCT06207123Phase 2Recruiting
- Sponsor
- University of Chicago
- Start
- Sep 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LP-118 in acute lymphoblastic leukemia (ALL), lymphoblastic lymphoma (LL), sponsored by University of Chicago. Started Sep 2024; status: recruiting.
02
Drugs
LP-118
03
Conditions
acute lymphoblastic leukemia (ALL)lymphoblastic lymphoma (LL)
Beyond the preview
Go deeper on NCT06207123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06207123.